Core Viewpoint - Celanese Corporation is conducting tender offers to purchase its senior notes, increasing the maximum tender amount and series cap for the notes due in 2027 and 2028, reflecting strong investor interest and adjustments in financial strategy [1][2][6]. Group 1: Tender Offer Details - The company announced early results indicating valid tenders of $946,106,000 for the 6.665% Senior Notes due 2027 and $675,185,000 for the 6.850% Senior Notes due 2028 [4]. - The maximum tender amount has been increased to $1,200,106,000 for the aggregate principal amount of the notes, and the series cap for the 2028 Notes is set at $254,000,000 [2][6]. - The total consideration for each $1,000 principal amount of the 2027 Notes and 2028 Notes validly tendered will be $1,037.50 and $1,055.00, respectively, including an early tender payment of $50.00 [7]. Group 2: Financial Conditions and Management - The interest rates on the 2027 Notes and 2028 Notes have increased to 7.165% and 7.350%, respectively, reflecting a 0.50% rise from their original stated coupons [4]. - The company has retained BofA Securities as the Lead Dealer Manager and D.F. King as the Information and Tender Agent for the tender offers [9]. - The financing condition for the tender offers has been satisfied, allowing the company to proceed with the purchase of the notes [8]. Group 3: Company Overview - Celanese Corporation is a global leader in chemistry, producing specialty material solutions across major industries, with 2024 net sales reported at $10.3 billion [18]. - The company employs over 11,000 individuals worldwide and is committed to sustainability and community impact [18].

The Celanese House is located in New Canaan, the suburban town known for Philip Johnson’s iconic Glass House. https://t.co/nkipuQIuqg ...

Core Insights - Celanese Corporation (CE) has received Carbon Footprint Certification from the International Sustainability & Carbon Certification (ISCC) for its Hostaform and Celcon POM ECO-C grades at production sites in Frankfurt, Germany, and Bishop, Texas, enabling customers to reduce carbon footprints and achieve sustainability goals [1][7] Group 1: Sustainability Initiatives - The certification highlights Celanese's commitment to transitioning to a circular economy, supported by significant investments in Carbon Capture and Utilization (CCU) technology at its Clear Lake, Texas facility, part of a joint venture with Mitsui & Co., Ltd. [2] - The CCU process effectively captures CO2 emissions and converts them into methanol, allowing for a reduction in fossil-based inputs while maintaining material performance [3] Group 2: Product Performance and Transparency - The certified products are recognized for their high stiffness, thermal stability, sliding performance, and wear resistance, contributing to overall sustainability efforts [3] - Celanese's digital assistant, AskChemille.com, provides Product Carbon Footprint letters, enhancing transparency and informed decision-making regarding Greenhouse Gas emissions [4] Group 3: Market Performance - Celanese's shares have declined by 40.8% over the past year, contrasting with the industry's 10.4% decline, indicating potential challenges in market performance [4] - In comparison, other companies in the Basic Materials sector, such as Kinross Gold Corporation, Fortuna Mining Corp., and Harmony Gold Mining Company, have shown stronger performance with significant increases in their share prices over the past year [5][8][9]

Core Insights - Celanese Corporation's subsidiary, Celanese US Holdings LLC, has announced a $1.4 billion registered notes offering, increased from an initial $1 billion, consisting of $600 million of 7% Senior Notes due 2031 and $800 million of 7.375% Senior Notes due 2034 [1][8] - The offering is expected to close around December 17, 2025, and the net proceeds will be used to repay outstanding borrowings under a five-year term loan due 2027 and to fund cash tender offers for certain Senior Notes due 2027 and 2028 [2][8] - The transaction aims to manage the company's debt maturity profile and strengthen liquidity, aligning debt maturities with a conservative outlook for free cash flow generation [3][8] Financial Performance - Celanese's shares have declined by 39.6% over the past year, while the industry has seen a smaller decline of 8.7% [4] - The company currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook compared to better-ranked stocks in the Basic Materials sector [5] Market Context - The move to issue new notes is part of Celanese's broader strategy to proactively manage leverage and maintain flexibility amid evolving market conditions [3][8]

Core Viewpoint - Celanese Corporation has initiated cash tender offers to purchase up to $1 billion of its outstanding senior notes, specifically targeting the 6.665% Senior Notes due 2027 and the 6.850% Senior Notes due 2028, with specific caps on the amount of each series to be purchased [1][2][4]. Group 1: Tender Offer Details - The total principal amount targeted for purchase is $1,000,000,000, with a cap of $100,000,000 for the 2028 Notes [1][4]. - The tender offers will expire at 5:00 p.m. New York City time on December 31, 2025, unless extended or terminated earlier [4][5]. - Notes purchased will be retired and cancelled following the tender offers [2][4]. Group 2: Financial Terms - The early tender payment for the 2027 Notes is set at $987.50 per $1,000 principal amount, while the total consideration including accrued interest is $1,037.50 [3]. - For the 2028 Notes, the early tender payment is $1,005.00, with a total consideration of $1,055.00 [3]. - The interest rates on the 2027 and 2028 Notes have increased to 7.165% and 7.350%, respectively, reflecting a 0.50% rise from their original rates [4]. Group 3: Conditions and Procedures - The tender offers are subject to a "Financing Condition," which requires the completion of a concurrent offering of new debt securities [6]. - Holders must validly tender their notes by December 15, 2025, to be eligible for the early tender payment [5][6]. - Notes can be withdrawn prior to the withdrawal deadline of December 15, 2025 [6][10]. Group 4: Management and Contacts - BofA Securities is the Lead Dealer Manager for the tender offers, with Citigroup, Deutsche Bank Securities, and TD Securities serving as Co-Dealer Managers [12]. - D.F. King & Co., Inc. is the Information and Tender Agent for the offers [12][13].

Core Insights - Uncertainty continues to dominate the situation for Celanese Corporation, with shares declining approximately 33% to around $36 [1] Group 1: Company Performance - Celanese Corporation's stock has experienced a significant drop, reflecting ongoing uncertainty in the market [1] Group 2: Investment Opportunities - The investment group "Value In Corporate Events" focuses on identifying actionable ideas related to major corporate events, including earnings reports and M&A activities [1]

Core Points - Celanese Corporation will participate in a fireside chat with J.P. Morgan on November 18, 2025, at 12:00 PM Eastern Time [1] - A webcast of the discussion will be available on Celanese's Investor Relations Events Calendar page, with a replay accessible for one year [2] Company Overview - Celanese Corporation is a global leader in specialty materials and chemicals, producing solutions used across major industries and consumer applications [3] - The company emphasizes sustainability by responsibly managing materials and expanding its portfolio of sustainable products to meet customer and societal demands [3] - Celanese is a Fortune 500 company with over 11,000 employees and projected net sales of $10.3 billion for 2024 [3]

Financial Performance - Net sales decreased by $229 million, or 9%, for the three months ended September 30, 2025, compared to the same period in 2024[161]. - Operating profit decreased by $1.5 billion, or 620%, for the three months ended September 30, 2025, compared to the same period in 2024[163]. - Net sales decreased by $570 million, or 7%, for the nine months ended September 30, 2025, compared to the same period in 2024[167]. - Operating profit decreased by $1.6 billion, or 226%, for the nine months ended September 30, 2025, compared to the same period in 2024[167]. - For the nine months ended September 30, 2025, total net sales amounted to $1.728 billion, with a gross profit of $31 million and a net loss of $830 million[227]. Segment Performance - Engineered Materials segment net sales decreased by 7% for the three months ended September 30, 2025, driven by lower volume and pricing[162]. - Acetyl Chain segment net sales decreased by 11% for the three months ended September 30, 2025, primarily due to lower pricing and volume[162]. - Net sales in the Engineered Materials segment decreased by $97 million, or 6.5%, for the three months ended September 30, 2025, compared to the same period in 2024[172]. - Operating profit in the Acetyl Chain segment decreased by $103 million, or 43.3%, for the three months ended September 30, 2025, compared to the same period in 2024[180]. - Net sales in the Acetyl Chain segment decreased by $129 million, or 10.8%, for the three months ended September 30, 2025, compared to the same period in 2024[180]. Earnings and Expenses - Equity in net earnings of affiliates decreased by $12 million, or 24%, for the three months ended September 30, 2025, primarily due to lower earnings from the Ibn Sina strategic affiliate[163]. - Equity in net earnings (loss) of affiliates decreased by $67 million, or 43%, for the nine months ended September 30, 2025, compared to the same period in 2024[168]. - SG&A expenses as a percentage of net sales were 9.5% for the three months ended September 30, 2025, compared to 9.4% for the same period in 2024[161]. - An unfavorable impact of $1.4 billion to Other (charges) gains, net, primarily due to an impairment loss on goodwill of $1.1 billion in the Engineered Materials segment[169]. Cash and Debt Management - Cash and cash equivalents increased to $1.44 billion as of September 30, 2025, compared to $962 million as of December 31, 2024[161]. - Total debt increased to $12.854 billion as of September 30, 2025, compared to $12.579 billion as of December 31, 2024[161]. - Net cash provided by operating activities increased by $422 million to $894 million for the nine months ended September 30, 2025, primarily due to favorable trade working capital of $576 million[198]. - Net cash used in financing activities decreased by $935 million to $189 million for the nine months ended September 30, 2025, primarily due to a decrease in common stock dividends paid by $221 million[199]. Future Outlook and Strategic Actions - The company anticipates challenges in achieving planned cost reductions and maintaining production costs amid macroeconomic uncertainties[155]. - The company expects to incur exit and shutdown costs of approximately $70 million to $90 million due to the intended closure of its facility in Lanaken, Belgium, with costs expected to be incurred from 2026 to 2028[190]. - A purchase and sale agreement was entered into with Element Solutions Inc to divest the Micromax portfolio for approximately $500 million in cash, expected to close in Q1 2026[191]. - Total capital expenditures are expected to be approximately $300 million to $350 million in 2025, focusing on maintenance projects and productivity improvements[193]. - The company plans to reduce its quarterly dividend by approximately 95% beginning in Q1 2025 as part of its deleveraging efforts[191]. Market Conditions and Demand - Demand challenges were experienced in key end-markets such as automotive, paints, coatings, and construction due to tepid global macroeconomic conditions[234]. - The company anticipates impacts to demand from western hemisphere seasonality and greater than usual year-end destocking in Q4 2025[234]. - Lower volume in the Engineered Materials and Acetyl Chain segments was primarily driven by weaker global economic conditions and decreased global demand[169]. Tax and Compliance - The effective income tax rate for the nine months ended September 30, 2025, was 6%, compared to 24% for the same period in 2024, primarily due to a non-cash goodwill impairment loss[168]. - Ongoing tax audits are in progress in multiple countries, including Mexico, Canada, the U.S., and Germany, with no expected material impact on income tax expense from these audits[232]. - The company is in compliance with the covenants in its material financing arrangements as of September 30, 2025[220]. - As of September 30, 2025, the company believes an adequate provision for income taxes has been made for all open tax years related to governmental examinations[233]. Risk Management - Market risk has not changed materially from previously disclosed foreign exchange, interest rate, and commodity risks[238]. - The preparation of financial statements requires management to make estimates and assumptions that could differ from actual results[235].

Core Insights - Celanese Corporation reported a significant loss from continuing operations of $12.39 per share for Q3 2025, a stark contrast to earnings of $1.05 in the same quarter last year [1] - Adjusted earnings were $1.34 per share, reflecting a 44.4% decline from $2.41 a year ago, but exceeded the Zacks Consensus Estimate of $1.27 [1][9] Revenue Performance - Revenues for the quarter totaled $2,419 million, down approximately 8.6% year over year, missing the Zacks Consensus Estimate of $2,460.5 million [2] - The decline in net sales was attributed to an 8% decrease in volumes in the Engineered Material segment and a 4% decrease in the Acetyl Chain segment [2] Segment Analysis - The Engineered Materials unit reported net sales of $1,384 million, a decrease of around 6.5% year over year, but surpassed the estimate of $1,348.2 million [3] - This segment incurred an operating loss of $1,327 million, with an adjusted EBIT of $200 million for the quarter [3] - The Acetyl Chain segment had net sales of $1,061 million, down roughly 10.8% year over year, missing the estimate of $1,111.5 million [4] - The Acetyl Chain segment generated an operating profit of $135 million and an adjusted EBIT of $187 million [4] Financial Position - Celanese ended the quarter with cash and cash equivalents of $1,440 million, reflecting a sequential increase of approximately 22.8% [5] - Long-term debt decreased by 8.1% sequentially to $11,655 million [5] - Cash provided by operating activities was $447 million, with free cash flow amounting to $375 million for the quarter [5] Future Outlook - The company anticipates volume declines in Q4 due to seasonality in the Western Hemisphere, although these will be partially offset by ongoing cost reduction initiatives [6] - Adjusted earnings per share for Q4 are expected to be between $0.85 and $1.00 [6] - Management is focused on generating cash flow to accelerate deleveraging, improving costs, and driving top-line growth, reaffirming progress towards a 2025 free cash flow target of $700 to $800 million [7] Stock Performance - Celanese's shares have experienced a 57.4% decline over the past year, compared to a 12.3% decline in the industry [8]

Financial Data and Key Metrics Changes - The company expects to grow EPS by $1 to $2 in 2026, driven by cost actions and progress from the EM pipeline, even in a flat demand environment [7][8] - Working capital has been a source of cash of $250 million in 2025, but a similar level is not expected in 2026 due to anticipated demand levels [37][38] - Free cash flow is projected to be at least $700-$800 million in 2026, supported by EBITDA improvements and reduced restructuring cash outlay [38] Business Line Data and Key Metrics Changes - Engineered materials volumes were down 8% year-over-year, with standard-grade materials experiencing more significant declines compared to thermoplastic elastomers, which showed growth [19][30] - The company is focusing on cost savings in engineered materials, targeting $30 million-$50 million in additional savings, net of inflation [48][49] Market Data and Key Metrics Changes - Pricing pressure in the acetyl chain has been observed, particularly in Europe, while stabilization and slight price increases were noted in China [17][18] - The company is not seeing extensive inventory destocking across the board, with some pockets of inventory reduction being managed thoughtfully [34][35] Company Strategy and Development Direction - The company is prioritizing cash flow increase, cost improvements, and top-line growth as it moves into 2026 [7] - A focus on divestitures continues, with a commitment to $1 billion in divestitures by the end of 2027, with the recent Micromax transaction contributing significantly towards this goal [54][56] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving EPS growth despite a challenging demand environment, emphasizing the resilience of the team and the actions taken to position the company for future success [78] - The dialogue around anti-involution in China is increasing, with expectations that profitability of assets in China needs to improve [80][81] Other Important Information - The company recorded a goodwill impairment due to a reduction in market cap, not due to a decline in projected cash flows [72] - The Narco enclosure is expected to yield $20 million-$30 million in productivity savings by 2027 [42] Q&A Session Summary Question: Early look at 2026 earnings control - Management highlighted priorities for 2026, focusing on cash flow, cost improvements, and top-line growth, with expected EPS growth of $1 to $2 [7] Question: EM pricing outlook - Management indicated that there are still opportunities for pricing improvements in EM, particularly in standard-grade materials [10] Question: Operating rates in the acetyl chain - Management noted that the lowest-cost assets are running at full capacity, while other assets are flexibly operated based on demand [13][14] Question: Sequential pricing pressure in the acetyl chain - Pricing pressure has been observed in Europe, particularly in downstream products, while stabilization has occurred in China [17][18] Question: Volume decline in engineered materials - The decline is primarily in standard-grade materials, while thermoplastic elastomers have shown resilience [19][30] Question: Free cash flow expectations - Working capital has been a source of cash in 2025, but similar contributions are not expected in 2026 [37][38] Question: Divestiture strategy - The company is committed to $1 billion in divestitures by 2027, with the Micromax transaction significantly contributing to this target [54][56] Question: Impact of anti-involution on acetyls chain - Management acknowledged the increasing dialogue around anti-involution in China and its potential future impact on profitability [80][81]